The family office of George Soros, Soros Fund Management LLC, continues to purchase shares in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), the fund's quarterly report to the US Securities and Exchange Commission (SEC) reveals. RELATED ARTICLES Sphera: Teva lacks growth engines Copaxone provided 63% of Teva's operating profit Goldman Sachs: Copaxone saved Teva in 2013 Teva seen as Valeant target Teva can't fall much further During the fourth quarter of 2013, Soros bought a further 5.7 million Teva shares, raising his holding in the Israeli pharmaceuticals company to some $373 million. Teva is the $9.8 billion fund's largest holding. In the third quarter of 2013, Soros bought 3.6 million Teva shares for some $136 million. Published by Globes [online], Israel business news - www.globes-online.com - on February 16, 2014 © Copyright of Globes Publisher Itonut (1983) Ltd. 2013
